These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6111198)

  • 21. Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins.
    Ze C; Kurata T; Tamura S
    Jpn J Infect Dis; 2000 Dec; 53(6):219-28. PubMed ID: 11227019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to the strain-specific and cross-reactive determinants of the haemagglutinin of influenza H3N2 virus. 3. Selection of antigenic variations in vitro and in vivo.
    Haaheim LR
    Acta Pathol Microbiol Scand B; 1980 Dec; 88(6):341-5. PubMed ID: 6164248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conserved determinants for CD4+ T cells within the light chain of the H3 hemagglutinin molecule of influenza virus.
    Jackson DC; Drummer HE; Brown LE
    Virology; 1994 Feb; 198(2):613-23. PubMed ID: 7507281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide.
    Kostolanský F; Mucha V; Slováková R; Varecková E
    Acta Virol; 2002; 46(4):229-36. PubMed ID: 12693859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on a recombinant influenza A virus by indirect neutralization.
    Majer M; Link F
    Z Immunitatsforsch Exp Klin Immunol; 1972 Jul; 144(1):96-9. PubMed ID: 4283242
    [No Abstract]   [Full Text] [Related]  

  • 26. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.
    Rodrigues M; Li S; Murata K; Rodriguez D; Rodriguez JR; Bacik I; Bennink JR; Yewdell JW; Garcia-Sastre A; Nussenzweig RS
    J Immunol; 1994 Nov; 153(10):4636-48. PubMed ID: 7525709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza.
    Shoji Y; Bi H; Musiychuk K; Rhee A; Horsey A; Roy G; Green B; Shamloul M; Farrance CE; Taggart B; Mytle N; Ugulava N; Rabindran S; Mett V; Chichester JA; Yusibov V
    Vaccine; 2009 Feb; 27(7):1087-92. PubMed ID: 19100806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant influenza-virus vaccines: II. Some properties of high-yielding recombinant influenza viruses and their vaccines.
    Higashihara M; Igarashi Y; Saito Y
    Kitasato Arch Exp Med; 1976 Jun; 49(1-2):27-41. PubMed ID: 1025340
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence for two T-helper populations with distinct specificity in the humoral response to influenza A viruses.
    Thomas DB; Hackett CJ; Askonas BA
    Immunology; 1982 Nov; 47(3):429-36. PubMed ID: 6215337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
    Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of an attenuated influenza A (H3N2) strain "KO-1" by recombination with A/Okuda/57 (H2N2) followed by selection of inhibitor-resistant virus.
    Yamada A; Okuno Y; Takahashi M; Nakajima K
    Biken J; 1980 Mar; 23(1):25-32. PubMed ID: 7437002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different neutralization efficiency of neutralizing monoclonal antibodies against avian influenza H5N1 virus to virus strains from different hosts.
    Huang H; Dan H; Zhou Y; Yu Z; Fan H; Tong T; Jin M; Chen H
    Mol Immunol; 2007 Feb; 44(5):1052-5. PubMed ID: 16965815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Isolation of monoclonal antibodies to influenza viruses].
    Iamnikova SS; Kurochkin SN; Gnuchev NV; Iurkif VA; Severin ES
    Vopr Virusol; 1983; 28(1):21-4. PubMed ID: 6845713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model.
    Ninomiya A; Imai M; Tashiro M; Odagiri T
    Vaccine; 2007 May; 25(18):3554-60. PubMed ID: 17293015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of gene constellation and postreassortment amino acid change on the phenotypic features of H5 influenza virus reassortants.
    Rudneva IA; Timofeeva TA; Shilov AA; Kochergin-Nikitsky KS; Varich NL; Ilyushina NA; Gambaryan AS; Krylov PS; Kaverin NV
    Arch Virol; 2007; 152(6):1139-45. PubMed ID: 17294090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the origin of pandemic influenza. IV. Selection and transmission of "new" influenza viruses in vivo.
    Webster RG; Campbell CH
    Virology; 1974 Dec; 62(2):404-13. PubMed ID: 4432372
    [No Abstract]   [Full Text] [Related]  

  • 38. Structural basis of immune recognition of influenza virus hemagglutinin.
    Wilson IA; Cox NJ
    Annu Rev Immunol; 1990; 8():737-71. PubMed ID: 2188678
    [No Abstract]   [Full Text] [Related]  

  • 39. Idiotypy of clonal responses of mice to influenza B virus hemagglutinin.
    Liu YN; Schulman JL; Bona CA
    Ann N Y Acad Sci; 1983; 418():356-62. PubMed ID: 6424531
    [No Abstract]   [Full Text] [Related]  

  • 40. Selection of influenza B virus recombinants and their testing in humans for attenuation and immunogenicity.
    Beare AS; Sherwood JE; Callow KA; Craig JW
    Infect Immun; 1977 Feb; 15(2):347-53. PubMed ID: 844900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.